S. Efendić

4.0k total citations · 1 hit paper
64 papers, 3.1k citations indexed

About

S. Efendić is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, S. Efendić has authored 64 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 28 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Epidemiology. Recurrent topics in S. Efendić's work include Pancreatic function and diabetes (17 papers), Neuroendocrine Tumor Research Advances (12 papers) and Diet and metabolism studies (9 papers). S. Efendić is often cited by papers focused on Pancreatic function and diabetes (17 papers), Neuroendocrine Tumor Research Advances (12 papers) and Diet and metabolism studies (9 papers). S. Efendić collaborates with scholars based in Sweden, United States and Denmark. S. Efendić's co-authors include Viktor Mutt, Kazuhiko Tatemoto, Gottfried J. Feistner, Jack D. Barchas, George Makk, Anders Thorell, R Luft, Alexandre Wajngot, Olle Ljungqvist and Claes‐Göran Östenson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

S. Efendić

62 papers receiving 3.0k citations

Hit Papers

Pancreastatin, a novel pa... 1986 2026 1999 2012 1986 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
S. Efendić 1.2k 1.1k 879 733 726 64 3.1k
John W. Ensinck 1.5k 1.2× 982 0.9× 1.4k 1.6× 342 0.5× 757 1.0× 65 3.4k
Jens F. Rehfeld 1.1k 0.9× 1.0k 0.9× 630 0.7× 1.0k 1.4× 399 0.5× 123 3.8k
Rolf Luft 1.4k 1.2× 1.8k 1.7× 1.8k 2.1× 446 0.6× 1.0k 1.4× 120 4.8k
Akihiro Funakoshi 1.5k 1.2× 991 0.9× 497 0.6× 1.0k 1.4× 514 0.7× 229 4.0k
André Dupont 595 0.5× 1.1k 1.0× 1.5k 1.7× 788 1.1× 333 0.5× 72 4.1k
N. Altszuler 876 0.7× 1.2k 1.1× 1.5k 1.7× 208 0.3× 1.6k 2.2× 99 4.0k
Lillian Recant 1.1k 0.8× 897 0.8× 1000 1.1× 368 0.5× 530 0.7× 124 2.9k
Jean Mockel 618 0.5× 1.1k 1.0× 2.1k 2.3× 377 0.5× 440 0.6× 78 3.7k
Anna M. Eisentraut 1.7k 1.3× 853 0.8× 2.0k 2.3× 311 0.4× 804 1.1× 29 3.5k
Charles J. Goodner 909 0.7× 742 0.7× 982 1.1× 184 0.3× 565 0.8× 75 2.3k

Countries citing papers authored by S. Efendić

Since Specialization
Citations

This map shows the geographic impact of S. Efendić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Efendić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Efendić more than expected).

Fields of papers citing papers by S. Efendić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Efendić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Efendić. The network helps show where S. Efendić may publish in the future.

Co-authorship network of co-authors of S. Efendić

This figure shows the co-authorship network connecting the top 25 collaborators of S. Efendić. A scholar is included among the top collaborators of S. Efendić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Efendić. S. Efendić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Östenson, Claes‐Göran, et al.. (2008). Loci of TCF7L2, HHEX and IDE on Chromosome 10q and the Susceptibility of their Genetic Polymorphisms to Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes. 117(4). 186–190. 16 indexed citations
2.
Höybye, Charlotte, et al.. (2008). Contribution of Gluconeogenesis and Glycogenolysis to Hepatic Glucose Production in Acromegaly before and after Pituitary Microsurgery. Hormone and Metabolic Research. 40(7). 498–501. 18 indexed citations
3.
Ding, Bo, et al.. (2005). Leu7Pro Polymorphism in the Neuropeptide Y (NPY) Gene is Associated with Impaired Glucose Tolerance and Type 2 Diabetes in Swedish Men. Experimental and Clinical Endocrinology & Diabetes. 113(5). 282–287. 44 indexed citations
4.
Agardh, Emilie, Anders Ahlbom, Tomas Andersson, et al.. (2004). Explanations of socioeconomic differences in excess risk of type 2 diabetes in Swedish men and women : Diabetes Care. Diabetes Care. 27(3). 15 indexed citations
5.
Agardh, Emilie, Anders Ahlbom, Tomas Andersson, et al.. (2003). Work stress and low sense of coherence is associated with type 2 diabetes in middle-aged Swedish women : Diabetes Care. Diabetes Care. 26(3). 13 indexed citations
6.
Nygren, Jonas, Mattias Soop, Anders Thorell, et al.. (1998). Preoperative oral carbohydrate administration reduces postoperative insulin resistance. Clinical Nutrition. 17(2). 65–71. 238 indexed citations
7.
Delaunay, Franck, Abdul Rehman Khan, A. Cintra, et al.. (1997). Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids.. Journal of Clinical Investigation. 100(8). 2094–2098. 261 indexed citations
8.
Persson, Bertil, Helmut Pschera, C Binder, et al.. (1993). Decreased Beta-Cell Function in Women with Previous Small for Gestational Age Infants. Hormone and Metabolic Research. 25(3). 170–174. 3 indexed citations
9.
Sten-Linder, Margareta, Anna Wedell, Thomas Pollare, et al.. (1991). Screening for insulin receptor gene DNA polymorphisms associated with glucose intolerance in a Scandinavian population. Diabetologia. 34(4). 265–270. 7 indexed citations
10.
Reinecke, M., Anders Höög, C-G Östenson, et al.. (1991). Phylogenetic aspects of pancreastatin- and chromogranin-like immunoreactive cells in the gastro-entero-pancreatic neuroendocrine system of vertebrates. General and Comparative Endocrinology. 83(2). 167–182. 38 indexed citations
11.
Ljungqvist, Olle, S. Efendić, M. Gutniak, T Häggmark, & Anders Thorell. (1991). Glucose infusion during preoperative fasting reduces postoperative development of insulin resistance. Clinical Nutrition. 10. 27–27. 1 indexed citations
12.
Thorell, Anders, S. Efendić, M. Gutniak, T Häggmark, & Olle Ljungqvist. (1991). Time course of postoperative insulin resistance. Clinical Nutrition. 10. 27–27. 1 indexed citations
13.
Nilsson, Inger, Torgny Svenberg, Per M. Hellström, et al.. (1990). Jejunal infusion with isotonic mannitol increases pancreatico-biliary output in man.. European Journal of Gastroenterology & Hepatology. 2(2). 155–160. 2 indexed citations
14.
Grill, Valdemar, Jan Pigon, S. G. Hartling, Christian Binder, & S. Efendić. (1990). Effects of dexamethasone on glucose-induced insulin and proinsulin release in low and high insulin responders. Metabolism. 39(3). 251–258. 67 indexed citations
16.
Efendić, S., et al.. (1978). Extrahypophyseal effects of somatostatin.. PubMed. 10(3). 151–6. 2 indexed citations
17.
Lins, P. E. & S. Efendić. (1976). Hyperglycemia Induced by Somatostatin in Normal Subjects. Hormone and Metabolic Research. 8(6). 497–498. 25 indexed citations
18.
Efendić, S., Kathryn T. Hall, T. Hökfelt, & R Luft. (1976). [Somatostatin and somatomedins--new hormones with connection to diabetes research and future diabetes therapy].. PubMed. 73(13). 1198–202. 1 indexed citations
19.
Efendić, S., et al.. (1976). AMNIOTIC-FLUID SOMATOMEDIN A AND FETAL C.N.S. DAMAGE. The Lancet. 307(7967). 1016–1016. 5 indexed citations
20.
Efendić, S., et al.. (1976). Studies on the mechanism of somatostatin action on insulin release. III. Effect of somatostatin on arginine induced release of insulin and glucagon in man and perfused rat pancreas.. PubMed. 81(4). 753–61. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026